These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7985534)
1. Multivariate prognostic model for infiltrating ductal carcinoma of the breast in the axillary node-free patient. Ceriani RL; Baratta F; Gaslonde RJ; De Rosa CM; Ozzello L Adv Exp Med Biol; 1994; 353():155-67. PubMed ID: 7985534 [No Abstract] [Full Text] [Related]
2. Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast. Chan CM; Baratta FS; Ozzello L; Ceriani RL Breast Cancer Res Treat; 1994; 30(3):243-61. PubMed ID: 7981443 [TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer. Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN Tumori; 2014; 100(1):80-6. PubMed ID: 24675496 [TBL] [Abstract][Full Text] [Related]
4. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351 [TBL] [Abstract][Full Text] [Related]
5. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of micrometastases in axillary lymph nodes in breast carcinoma]. Stosiek P; Gerber B; Kasper M Pathologe; 1996 Nov; 17(6):433-9. PubMed ID: 9082364 [TBL] [Abstract][Full Text] [Related]
7. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma. Xiao J; Zhou Y; Zhu W Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424 [TBL] [Abstract][Full Text] [Related]
9. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537 [TBL] [Abstract][Full Text] [Related]
10. Benign Müllerian inclusions coexisting with breast metastatic carcinoma in an axillary lymph node. Piana S; Asioli S; Cavazza A Virchows Arch; 2005 Apr; 446(4):467-9. PubMed ID: 15785927 [No Abstract] [Full Text] [Related]
12. [Proliferation index and its prognostic value in invasive ductal breast carcinoma]. Falco M Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors. Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338 [TBL] [Abstract][Full Text] [Related]
14. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200 [TBL] [Abstract][Full Text] [Related]
15. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma. Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683 [TBL] [Abstract][Full Text] [Related]
16. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis]. Liao YQ; Xu BH Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884 [TBL] [Abstract][Full Text] [Related]
17. Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis. Zeichner SB; Cavalcante L; Suciu GP; Ruiz AL; Hirzel A; Krill-Jackson E Asian Pac J Cancer Prev; 2014; 15(8):3435-41. PubMed ID: 24870735 [TBL] [Abstract][Full Text] [Related]
18. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis. Ceriani RL; Chan CM; Baratta FS; Ozzello L; DeRosa CM; Habif DV Int J Cancer; 1992 May; 51(3):343-54. PubMed ID: 1592525 [TBL] [Abstract][Full Text] [Related]
19. [Axillary skip metastases in breast cancer]. Sun JY; Ning LS Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):352-5. PubMed ID: 18953834 [TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis. Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]